Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)

NCT07729397 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma (DLBCL)
Hodgkin Lymphoma
Peripheral T-cell Lymphoma (PTCL)
Anaplastic Large Cell Lymphoma, ALK-Positive
Anaplastic Large Cell Lymphoma, ALK-Negative

Interventions

BIOLOGICAL: Autologous C7R.CD30-CAR-EBVSTs

Sponsor

The Methodist Hospital Research Institute

Collaborators

[object Object]